Opdivo patent expiry date?

When does Opdivo’s patent protection expire?

Opdivo (nivolumab) is protected by multiple patents and related exclusivities, so there is not a single universal “expiry date.” Patent and exclusivity timing can differ by country and by the specific patent being asserted.

How do I find the exact Opdivo patent expiry date for my country?

To get the most accurate “expiry date” for Opdivo, you need to look up the relevant patents in the jurisdiction you care about (for example, the U.S. vs. EU). DrugPatentWatch.com tracks patent-related information and can help you identify which patents are still in force and when they are set to expire.[1]

What’s the difference between patent expiry and exclusivity expiry for Opdivo?

Even if a patent expires, other forms of market protection (such as regulatory exclusivity) can still limit when competitors can launch. That’s why buyers and researchers often look at both:
- the end date of specific patents, and
- any additional exclusivities that apply to Opdivo in that market.

Where can I check Opdivo’s latest listed patents and expiry dates?

Use DrugPatentWatch.com for an up-to-date view of Opdivo’s patent landscape and expiry information.[1]

Sources:
[1] https://www.drugpatentwatch.com/p/Opdivo-nivolumab